4//SEC Filing
Van Vliet David A 4
Accession 0001140361-09-010586
CIK 0000057055other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 6:06 PM ET
Size
12.2 KB
Accession
0001140361-09-010586
Insider Transaction Report
Form 4
KV PHARMACEUTICAL CO /DE/KVA / KVB
Van Vliet David A
Interim Pres./ Interim CEO, KV
Transactions
- Award
Option to Purchase
2009-04-24+50,000→ 50,000 totalExercise: $1.52Exp: 2019-04-24→ Class A Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests in two installments: 50% on December 31, 2009 and 50% on December 31, 2010.
Documents
Issuer
KV PHARMACEUTICAL CO /DE/
CIK 0000057055
Entity typeother
Related Parties
1- filerCIK 0001296310
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 6:06 PM ET
- Size
- 12.2 KB